OMKARPH

Omkar Pharmachem financials

Market cap
₹27 Cr

Quarterly results

Q1 FY27: revenue down 35.7%, net profit down 133.3% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue0 0 0 0 0 +0%0 −21%0 −36%0 −36%
EBITDA0 0 0 0 0 −22%0 −56%0 −71%-0 −125%
Net profit0 0 -0 0 0 −44%0 −62%0 +200%-0 −133%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Performance −70.4% 1Y

₹10.0₹15.0₹20.0₹25.0₹30.0Sept 25Dec 25Feb 26Apr 26Jun 26Jul 26Aug 26

1Y: ₹25.56 on 9 Sept 2025 → ₹7.57. High ₹29.74 (15 Dec 2025), low ₹7.57 (10 Sept 2026).

Financials, as filed

Revenue fell 7.4% a year over 2 years, FY24 to FY26. Operating margin narrowed to 35.4%.

Year endingFY24FY25FY26
Revenue₹1 Cr₹1 Cr₹0 Cr
Operating profit₹0 Cr₹0 Cr₹0 Cr
Operating margin51.8%53.6%35.4%
Interest₹0 Cr₹0 Cr₹0 Cr
Depreciation₹0 Cr₹0 Cr₹0 Cr
Net profit₹0 Cr₹0 Cr₹0 Cr
Net margin33.9%35.7%27.1%
Cash from operations₹0 Cr₹0 Cr₹0 Cr
Free cash flow₹0 Cr₹0 Cr₹0 Cr
ROCE3.0%3.0%0.7%
How to read this

From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.

Balance sheet

Year endingFY21FY22FY23FY24FY25FY26
Equity capital₹10 Cr₹10 Cr₹10 Cr₹10 Cr₹10 Cr₹10 Cr
Reserves₹-1 Cr₹-1 Cr₹-1 Cr₹-1 Cr₹-1 Cr₹27 Cr
Borrowings₹1 Cr₹1 Cr₹1 Cr₹0 Cr₹0 Cr₹0 Cr
Other liabilities₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Total liabilities₹10 Cr₹10 Cr₹10 Cr₹10 Cr₹10 Cr₹37 Cr
Fixed assets₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Capital work in progress₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Investments₹9 Cr₹9 Cr₹9 Cr₹9 Cr₹9 Cr₹36 Cr
Other assets₹0 Cr₹1 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Total assets₹10 Cr₹10 Cr₹10 Cr₹10 Cr₹10 Cr₹37 Cr
How to read this

As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.

Who owns it

As disclosed at Jun 2026

The ownership split has held steady since Jun 2025. The shareholder count grew 1% to 3,669.

Promoters
0.0%
Public
100.0%

Since Jun 2025

  • Promoters 0.00 pp
  • Public 0.00 pp

How it drifted, 12 quarters

Sep '23Dec '24Jun '26

Ownership split by quarter, oldest first. Sep '23: Promoters 0.0%, Public 100.0%.Dec '23: Promoters 0.0%, Public 100.0%.Mar '24: Promoters 0.0%, Public 100.0%.Jun '24: Promoters 0.0%, Public 100.0%.Sep '24: Promoters 0.0%, Public 100.0%.Dec '24: Promoters 0.0%, Public 100.0%.Mar '25: Promoters 0.0%, Public 100.0%.Jun '25: Promoters 0.0%, Public 100.0%.Sep '25: Promoters 0.0%, Public 100.0%.Dec '25: Promoters 0.0%, Public 100.0%.Mar '26: Promoters 0.0%, Public 100.0%.Jun '26: Promoters 0.0%, Public 100.0%.

Who was buying across the market this quarter →

Who is on the register

Named in the Jun 2026 filing

Every holder of Omkar Pharmachem Ltd. above SEBI's 1% disclosure line, and what changed since Mar 2026.

HolderStakeChange
Kuldeepsingh . 3.72%unchanged
Sanjeev Saxena 2.94%unchanged
Bhag Singh 2.48%unchanged
Resam Singh 2.48%unchanged
Akshay Saxena 1.98%unchanged
Navneet Kumar Saxena 1.93%unchanged
Ahsan Ali Khan 1.83%unchanged
Rajesh Sharma 1.79%unchanged
Manoj Kumar Singh 1.76%unchanged
Radheshyam Yadav 1.74%unchanged
Jitender Singh 1.74%unchanged
Ashok Kumar Tiwari 1.64%unchanged

A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.

Learn to analyse Omkar Pharmachem Ltd.

Guides on how to read this kind of business and the numbers that matter.